Reports
Reports
Sale
The Canada diabetes market is growing at a CAGR of 8.4% between 2021 and 2026. The industry contributes to the growth of the North America diabetic devices market, which attained a value of USD 9.7 billion in the year 2020 and is expected to grow at a CAGR of 9% in the forecast period of 2024-2032 to reach USD 16.3 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America is a significant market for diabetes, which has witnessed an exponential growth of diabetes patients in recent years. The developed countries in North America, namely Canada and the United States, have a high rate of diabetes, mainly due to lifestyle changes. On account of this, the sale of insulin, a diabetic device, has rapidly increased in the region. Insulin, which was initially used to treat type 1 diabetic patients exclusively, is now used as a treatment method by a substantial amount of type 2 patients.
Diabetes is referred to as a chronic ailment caused by the sugar spikes in the body due to inappropriate production of or response of the body to insulin. Diabetes has adverse effects on the body's ability to break down sugar absorbed from food or generate an adequate amount of insulin. Uncontrolled diabetes can cause a variety of problems, such as visual, renal, cardiovascular, and neural disorders.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on the segment, the Canada diabetes market is divided into:
The regional markets can be divided into British Columbia, Alberta, the Prairies, Central Canada, and Atlantic Canada.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The Canada diabetes market is driven by the rising rate of obesity, spurring stress levels, and inefficient exercise within the country. The industry is further aided by the rising demand for insulin, which has resulted in tremendous R&D activities in producing various painless types of insulin deliverable devices, like integrated insulin pumps, continuous glucose monitoring (CGM), improved lancets for a glucometer, and enormously accurate blood glucose monitoring devices (for instance, the flash glucose monitoring device).
The Canada diabetes market is witnessing a growth due to various advancements taking place in the industry. Initially, the insulin was given through syringes, which are considered painful and hard to use. Now, companies like Sanofi and Novo Nordisk, among others, have innovated insulin pens with a specific set dosage. Usage of this pen reduces insulin wastage and is less painful to use. The only drawback that might affect the Canada diabetes market growth is the high cost of insulin pens.
The report gives a detailed analysis of the following key players in the Canada diabetes market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model, along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Segment |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Canada
6.2 Regional
7 Opportunities and Challenges in the Market
8 Canada Diabetes Epidemiology
8.1 Diabetes Population and Prevalence Rates
8.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
8.3 Population and Prevalence Rates by Region
8.4 Population and Prevalence Rates by Gender
8.5 Population and Prevalence Rates by Age Group
9 Canada Diabetes Market Analysis
9.1 Key Industry Highlights
9.2 Canada Diabetes Historical Market (2018-2023)
9.3 Canada Diabetes Market Forecast (2024-2032)
9.4 Canada Diabetes Market by Segment
9.4.1 Canada Oral Antidiabetics Market
9.4.1.1 Historical Trend (2018-2023)
9.4.1.2 Forecast Trend (2024-2032)
9.4.1.3 Market by Class
9.4.1.4 Market Share by Key Players
9.4.2 Canada Insulin Market
9.4.2.1 Historical Trend (2018-2023)
9.4.2.2 Forecast Trend (2024-2032)
9.4.2.3 Market by Class
9.4.2.4 Market Share by Key Players
9.5 Canada Diabetes Market by Region
9.5.1 British Columbia
9.5.2 Alberta
9.5.3 The Prairies
9.5.4 Central Canada
9.5.5 Atlantic Canada
10 Regional Analysis
10.1 British Columbia
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Alberta
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 The Prairies
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Central Canada
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Atlantic Canada
10.5.1 Historical Trend (2018-2023)
10.5.2 Forecast Trend (2024-2032)
11 Market Dynamics
11.1 SWOT Analysis
11.1.1 Strengths
11.1.2 Weaknesses
11.1.3 Opportunities
11.1.4 Threats
11.2 Porter’s Five Forces Analysis
11.2.1 Supplier’s Power
11.2.2 Buyers Power
11.2.3 Threat of New Entrants
11.2.4 Degree of Rivalry
11.2.5 Threat of Substitutes
11.3 Key Indicators for Demand
11.4 Key Indicators for Price
12 Value Chain Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Company Profiles
13.2.1 Abbott
13.2.1.1 Company Overview
13.2.1.2 Demographic Reach and Achievements
13.2.1.3 Certifications
13.2.2 Dexcom
13.2.2.1 Company Overview
13.2.2.2 Demographic Reach and Achievements
13.2.2.3 Certifications
13.2.3 F. Hoffmann-La Roche Ltd
13.2.3.1 Company Overview
13.2.3.2 Demographic Reach and Achievements
13.2.3.3 Certifications
13.2.4 Medtronic Canada
13.2.4.1 Company Overview
13.2.4.2 Demographic Reach and Achievements
13.2.4.3 Certifications
13.2.5 Others
14 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Canada Diabetes Market: Key Industry Highlights, 2018 and 2032
2. Canada Diabetes Epidemiology: Diabetes Population and Prevalence Rates
3. Canada Diabetes Epidemiology: Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
4. Canada Diabetes Epidemiology: Population and Prevalence Rates by Region
5. Canada Diabetes Epidemiology: Population and Prevalence Rates by Gender
6. Canada Diabetes Epidemiology: Population and Prevalence Rates by Age Group
7. Canada Diabetes Historical Market: Breakup by Segment (USD Billion), 2018-2023
8. Canada Diabetes Market Forecast: Breakup by Segment (USD Billion), 2024-2032
9. Canada Diabetes Historical Market: Breakup by Region (USD Billion), 2018-2023
10. Canada Diabetes Market Forecast: Breakup by Region (USD Billion), 2024-2032
11. Canada Diabetes Market Structure
The industry contributes to the growth of the North America diabetic devices market, which attained a value of USD 9.7 billion in the year 2020.
The market is projected to grow at a CAGR of nearly 8.4% in the forecast period of 2024-2032.
The market is estimated to be aided by the North America diabetes market, which is expected to reach a value of about USD 16.3 billion by 2026, growing at CAGR of 9% between 2021 and 2026.
The major drivers of the market include rising prevalence of diabetes, increasing population, rising demand for insulin, and growing stress levels.
Technological advancements taking place for diabetes detection, monitoring, and treatment and rising rate of obesity are expected to be key trends guiding the growth of the market.
British Columbia, Alberta, the Prairies, Central Canada, and Atlantic Canada are the leading regions in the market.
The major segments of the market are the Canada oral antidiabetics market and the Canada insulin market.
The leading players in the Canada diabetes market are Abbott, Dexcom, F. Hoffmann-La Roche Ltd, and Medtronic Canada, among others.
The Canada diabetes market contributes to the growth of the North America diabetic devices market, which attained a value of USD 9.7 billion in the year 2020, driven by the rising rate of obesity and inefficient exercise levels. Aided by the technological advancements, the North America diabetic devices market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 9%, thus, further boosting the Canada diabetes market.
EMR's meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. Based on its segments, the industry for diabetes in Canada can be segmented into Canada oral antidiabetics and insulin markets. The major regional markets in the industry in Canada are British Columbia, Alberta, the Prairies, Central Canada, and Atlantic Canada. The key players in the above industry include Abbott, Dexcom, F. Hoffmann-La Roche Ltd, and Medtronic Canada, among others.
EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with industry insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.